Glipizide and Metformin Hydrochloride (Teva Pharmaceuticals USA, Inc.)
Welcome to the PulseAid listing for the Glipizide and Metformin Hydrochloride drug offered from Teva Pharmaceuticals USA, Inc.. This Sulfonylurea [EPC],Sulfonylurea Compounds [Chemical/Ingredient],Biguanide [EPC],Biguanides [Chemical/Ingredient] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Teva Pharmaceuticals USA, Inc. |
| NON-PROPRIETARY NAME: | Glipizide and Metformin Hydrochloride |
| SUBSTANCE NAME: | GLIPIZIDE; METFORMIN HYDROCHLORIDE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Sulfonylurea [EPC],Sulfonylurea Compounds [Chemical/Ingredient],Biguanide [EPC],Biguanides [Chemical/Ingredient] |
| ROUTE: | ORAL |
| DOSAGE FORM: | TABLET, FILM COATED |
| MARKETING CATEGORY NAME: | ANDA |
| START MARKETING DATE: | 2005-10-28 |
| END MARKETING DATE: | 0000-00-00 |
Glipizide and Metformin Hydrochloride HUMAN PRESCRIPTION DRUG Details:
| Item Description | Glipizide and Metformin Hydrochloride from Teva Pharmaceuticals USA, Inc. |
| LABELER NAME: | Teva Pharmaceuticals USA, Inc. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 2.5; 250(mg/1; mg/1) |
| START MARKETING DATE: | 2005-10-28 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 0093-7455_302ae210-7009-40cb-a74f-e5b7100de7e1 |
| PRODUCT NDC: | 0093-7455 |
| APPLICATION NUMBER: | ANDA077270 |
Other GLIPIZIDE; METFORMIN HYDROCHLORIDE Pharmaceutical Manufacturers / Labelers:
